How many email patterns does Imugene Limited use?

Imugene Limited uses 3 known email patterns.

What domain does Imugene Limited use for work emails?

Imugene Limited uses imugene.com for work email addresses.

Most Common Email Formats at Imugene Limited

Imugene Limited's most common email format is FLast@imugene.com (ex. JDoe@imugene.com), used for 82% of imugene.com addresses. Imugene Limited uses 3 email patterns.

@imugene.com

3 patterns

Format	Example	Share of imugene.com
FLast@imugene.comMost common	JDoe@imugene.com	82%
First.Last@imugene.com	John.Doe@imugene.com	16%
FL@imugene.com	JD@imugene.com	2%

Need a specific person's email?

Browse Imugene Limited's employee directory (about 28 employees) and reveal verified emails free.

Frequently Asked Questions

What does Imugene Limited do?

Imugene Limited was founded in 2013 and operates in the Biotechnology Research industry, alongside similar companies like Roche, Sanofi and Johnson & Johnson. You can visit imugene.com or contact Imugene Limited's headquarters by phone at

+61-3-9824-****

. Explore Imugene Limited's company overview page for more information.

What is Imugene Limited's email address format?

Imugene Limited's email format typically follows the pattern of FLast@imugene.com; this email format is used 82% of the time. Other contacts within LeadIQ's database had email formats such as First.Last@imugene.com and FL@imugene.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Imugene Limited have currently?

Imugene Limited has approximately 28 employees as of October 2026. Key team members to contact include Chief Executive Officer: L. C., Vice President Technical Operations: G. G. and Executive Chairman & Founder: P. H. For more team information and contact data, explore Imugene Limited's employee directory with LeadIQ.

Imugene Limited Email Format

Biotechnology ResearchNew South Wales, Australia11-50 Employees

Imugene Limited is a clinical-stage biotechnology company focused on immuno-oncology, aiming to activate the patient’s immune system to fight and eradicate tumors. Its pipeline includes immunotherapy approaches such as B-cell vaccines and an oncolytic virotherapy called CF33, designed to treat a range of cancers in combination with standard therapies and emerging immunotherapies. Based in Sydney, New South Wales, the company operates as a small to mid-sized biotechnology firm supported by a team of international cancer experts with broad experience in developing new cancer therapies for global markets. In 2025, Imugene announced participation at ASH 2025, with an abstract related to its azer-cel program selected for oral presentation. The company is listed on the Australian Securities Exchange under the ticker IMU.

Most common format

FLast@imugene.com

Example: JDoe@imugene.com

3 patterns. See all formats

Verify a Imugene Limited email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Imugene Limited

@imugene.com

Need a specific person's email?

Frequently Asked Questions

What does Imugene Limited do?

What is Imugene Limited's email address format?

How many employees does Imugene Limited have currently?

Imugene Limited Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.